Connect with us
Information

WORLD EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

WORLD EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Company Profiles Market

Company Profiles News

Company Profiles Stocks

Company Profiles Market
Company Profiles News
Company Profiles Stocks

Novartis AG

NYSE:NVS:US

Featured Articles and Interviews

Feb 11, 2025

What is In-Licensing?

Jan 23, 2025

5 US Longevity and Anti-aging Stocks to Watch in 2025

Jan 22, 2025

Biotech Market Forecast: Top Trends for Biotech in 2025

More Featured Articles and Inverviews

Press Releases

More Press Releases

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Go Deeper

AI Powered

Microscopic view of stem cells.

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Two vials labelled H5N1 Vaccine. One stands and one lays on its side behind the first.

Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Interactive Chart

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.